相关实验视频

Updated: Jan 18, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

利用cuproptosis:针对癌症向治疗的新途径

Anil Dharavath¹, Sivkan Kaur¹, P V Drupad Mohan¹

¹Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Balanagar, Kukatpally, Hyderabad, Telangana, 500037, India.

Apoptosis : an international journal on programmed cell death

|September 12, 2025

概括

超量铜引发的一种新型细胞死亡途径cuproptosis提供了一种新的癌症治疗策略. 这种机制涉及线粒体功能障碍和蛋白质毒性压力,与亡不同,并呈现出新的治疗点.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
在瘤学瘤学.

背景情况:

铜对于酶是必不可少的,但在高度下有毒.
cuproptosis是一种独特的细胞死亡机制,涉及线粒体损伤和蛋白质毒性压力.
铜平衡和相关基因 (FDX1,LIAS,DLAT) 的破坏与癌症的发展有关.

研究的目的:

审查发现和cuproptosis的机制.
在人类生理学中探索铜的恒温和新陈代谢.
检查cuproptosis在瘤发生中的作用,并确定治疗点.

主要方法:

关于cuproptosis发现和机制的文献综述.
分析铜的平衡,新陈代谢及其与癌症的联系.
关于cuproptosis相关基因及其在癌症中的作用的概述.
针对cuproptosis的药物的汇编及其临床相关性.

主要成果:

型亡的特征是线粒体功能障碍,这是由于TCA周期内的铜-化相互作用造成的.
改变铜平衡和特定基因失调与各种癌症有关.
已经确定了许多与cuproptosis相关的基因和药物,显示出治疗潜力.

结论:

型亡代表了一种新的细胞死亡途径,对癌症治疗有重大影响.
向cuproptosis为癌症治疗开发提供了一个有希望的新途径.
对cuproptosis机制和药物开发的进一步研究是有必要的.

关键词:

癌症癌症癌症癌症细胞死亡细胞死亡铜铜铜铜铜铜这种疾病叫做cuproptosis.机理机制机理机制代谢过程中的代谢.线粒体中的线粒体.

更多相关视频

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...